Description
This product is a recombinant fully human anti-CTLA4 monoclonal antibody can suppress growth of tumor cells significantly, and has wide application prospects in resisting tumor, resisting infection and treating autoimmune diseases.
Target
CTLA4
Target Alias Names
CD, GSE, GRD4, ALPS5, CD152, CTLA-4, IDDM12, CELIAC3, cytotoxic T-lymphocyte protein 4, CD152 isoform, celiac disease 3, cytotoxic T lymphocyte associated antigen 4 short spliced form, cytotoxic T-lymphocyte-associated serine esterase-4, insulin-dependent diabetes mellitus 12, ligand and transmembrane spliced cytotoxic T lymphocyte associated antigen 4
Isotype/Mimetic
Human IgG
Animal-Derived Biomaterials Used
None
Sequence Available
No
Original Discovery Method
Human-derived phage display
Original Discovery Information Provided On Datasheet
No
Antibody/Binder Origins
Animal-free discovery, In vitro recombinant expression